[ad_1]
According to the statement, Ozone launched its Molecule initiative with a vision to become the world’s foremost pain management company.
“Embracing a legacy spanning three decades, the Ozone Group has witnessed a remarkable ascent, elevating our ranks from 84 to 56 in the last four years,” its CMD SC Sehgal said.
With a strategic vision, our next three-year plan is set to ambitiously propelling from 56 to the top 20 pharmaceutical companies in India and a turnover of Rs 1,000 crore, Sehgal stated.
Ozone Pharmaceuticals Group Director Saurav Banerjee said the company’s mission emphasises the commitment to “adding years to life and life to years”.
[ad_2]
Source link